{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T06:00:21Z","timestamp":1785218421491,"version":"3.55.0"},"reference-count":33,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Metabolic dysfunction-associated steatotic liver disease (MASLD) increases cardiovascular risk, but non-invasive tools for risk stratification are limited. The C-reactive protein\u2013triglyceride\u2013glucose (CTI) index integrates metabolic and inflammatory pathways, but its value in MASLD is unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We examined the association between CTI and obstructive coronary artery disease (CAD) in MASLD patients who underwent coronary computed tomography angiography. Machine-learning-assisted feature selection was used to assess the relative stability of CTI among candidate clinical variables, and multivariable logistic regression was used to evaluate its independent association with obstructive CAD. Discriminative performance was assessed using ROC curves, calibration analysis, clinical impact analysis, and restricted cubic spline analysis, with sex-stratified and sensitivity analyses. The prognostic relevance of CTI for all-cause and cardiovascular mortality was further evaluated in a population-based NHANES MASLD cohort.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Higher CTI quartiles correlated with greater metabolic burden and CAD prevalence (P &amp;lt; 0.001). CTI was independently associated with obstructive CAD (OR\u00a0=\u00a01.68, 95% CI 1.33\u20132.12), with a graded association across quartiles. CTI showed moderate apparent discrimination for obstructive CAD, with higher AUCs than FIB-4, TyG-BMI, and TyG in the overall, male, and female populations. In the NHANES cohort, elevated CTI was associated with increased risks of all-cause and cardiovascular mortality, with the association for cardiovascular mortality being more evident in men than in women after full adjustment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>CTI was independently associated with CCTA-defined obstructive CAD in a high-risk MASLD cohort and showed prognostic relevance for long-term mortality in a population-based MASLD cohort.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2026.1864536","type":"journal-article","created":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T05:37:35Z","timestamp":1785217055000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Sex differences in the association of the CRP-TyG index with coronary artery disease and long-term mortality in MASLD"],"prefix":"10.3389","volume":"17","author":[{"given":"Lin","family":"Shi","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, Xuzhou Central Hospital, Southeast University","place":["Xuzhou, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sen","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Xuzhou Central Hospital, Southeast University","place":["Xuzhou, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Du","sequence":"additional","affiliation":[{"name":"Department of Neurology, Xuzhou Central Hospital, Southeast University","place":["Xuzhou, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renwei","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Xuzhou Central Hospital, Southeast University","place":["Xuzhou, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1097\/hep.0000000000000520","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"79","author":"Rinella","year":"2023","journal-title":"J Hepatol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.05.025","article-title":"EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis - 2021 update","volume":"75","author":"Electronic address","year":"2021","journal-title":"J Hepatol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabet.2023.101506","article-title":"Steatotic liver disease, MASLD and risk of chronic kidney disease","volume":"50","author":"Bilson","year":"2024","journal-title":"Diabetes Metab"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2020-323082","article-title":"Non-alcoholic fatty liver disease and risk of incident chronic kidney disease: an updated meta-analysis","volume":"71","author":"Mantovani","year":"2022","journal-title":"Gut"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.04.036","article-title":"Changing epidemiology, global trends and implications for outcomes of NAFLD","volume":"79","author":"Wong","year":"2023","journal-title":"J Hepatol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1161\/circulationaha.124.070535","article-title":"Cardiovascular-liver-metabolic health: recommendations in screening, diagnosis, and management of metabolic dysfunction-associated steatotic liver disease in cardiovascular disease via modified delphi approach","volume":"151","author":"Chew","year":"2025","journal-title":"Circulation"},{"key":"B7","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1186\/s12933-024-02434-5","article-title":"Metabolic dysfunction-associated steatotic liver disease and cardiovascular risk: a comprehensive review","volume":"23","author":"Zheng","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1177\/2047487319891783","article-title":"Non-alcoholic fatty liver disease, a new and growing risk indicator for cardiovascular disease","volume":"27","author":"Janssen","year":"2020","journal-title":"Eur J Prev Cardiol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"117\u20138","DOI":"10.1038\/s41575-025-01144-x","article-title":"Heart-liver co-management in MASLD: from concept to clinical practice","volume":"23","author":"Zhou","year":"2025","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2023.03.011","article-title":"The predictive value of left atrium epicardial adipose tissue on recurrence after catheter ablation in patients with different types of atrial fibrillation","volume":"379","author":"Sang","year":"2023","journal-title":"Int J Cardiol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-10451-1_9","article-title":"Triglyceride glucose index is associated with obstructive coronary artery disease in hypertensive patients","volume":"22","author":"Pan","year":"2023","journal-title":"Cardiovasc Diabetol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s12933-020-01108-2","article-title":"Triglyceride glucose index for the detection of asymptomatic coronary artery stenosis in patients with type 2 diabetes","volume":"19","author":"Thai","year":"2020","journal-title":"Cardiovasc Diabetol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"394\u2013406","DOI":"10.1016\/j.cgh.2025.07.011","article-title":"Longitudinal changes in fibrosis markers: monitoring stiffness\/fibrosis progression and prognostic outcomes in MASLD","volume":"24","author":"Zhou","year":"2025","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1186\/s12888-024-06336-4","article-title":"Association between C-reactive protein-triglyceride glucose index and depressive symptoms in American adults: results from the NHANES 2005 to 2010","volume":"24","author":"Huang","year":"2024","journal-title":"BMC Psychiatry"},{"key":"B15","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s12933-025-02686-9","article-title":"Association between C-reactive protein-triglyceride glucose index and stroke risk in different glycemic status: insights from the China Health and Retirement Longitudinal Study (CHARLS)","volume":"24","author":"Huo","year":"2025","journal-title":"Cardiovasc Diabetol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1186\/s12933-025-02835-0","article-title":"Association of C-reactive protein-triglyceride glucose index with the incidence and mortality of cardiovascular disease: a retrospective cohort study","volume":"24","author":"Sun","year":"2025","journal-title":"Cardiovasc Diabetol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1186\/s12872-025-05143-3","article-title":"C-reactive protein-triglyceride glucose index and stroke risk in early cardiovascular-kidney-metabolic syndrome: a National cohort study","volume":"25","author":"Xu","year":"2025","journal-title":"BMC Cardiovasc Disord"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgae745","article-title":"Cardiometabolic risk assessment in transgender individuals-differential effect of sex hormones and sex chromosomes","volume":"110","author":"Lei","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"key":"B19","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41574-020-00431-8","article-title":"Sexual dimorphism in cardiometabolic health: the role of adipose tissue, muscle and liver","volume":"17","author":"Goossens","year":"2021","journal-title":"Nat Rev Endocrinol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.2534","article-title":"Distinct pathophysiological pathways in women and men with heart failure","volume":"24","author":"Ravera","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.exger.2023.112296","article-title":"Association of energy-adjusted dietary inflammatory index and frailty in older adults with nonalcoholic fatty liver disease","volume":"182","author":"Shi","year":"2023","journal-title":"Exp Gerontol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1186\/s12889-023-16338-8","article-title":"Association between systemic immune-inflammation index and low muscle mass in US adults: a cross-sectional study","volume":"23","author":"Shi","year":"2023","journal-title":"BMC Public Health"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1016\/j.cgh.2023.11.003","article-title":"Prevalence of steatotic liver disease (MASLD, metALD, and ALD) in the United States: NHANES 2017-2020","volume":"22","author":"Kalligeros","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpc.2025.101003","article-title":"Association between arterial stiffness and MASLD in US young adults: base on NHANES 2005-2018","volume":"22","author":"Li","year":"2025","journal-title":"Am J Prev Cardiol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1101\/2023.09.26.23296130","article-title":"Comparison of NAFLD, MAFLD and MASLD characteristics and mortality outcomes in United States adults","volume":"44","author":"Song","year":"2024","journal-title":"Liver Int"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.01.006","article-title":"Artificial intelligence, machine learning, and deep learning in liver transplantation","volume":"78","author":"Bhat","year":"2023","journal-title":"J Hepatol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1186\/s13054-024-05138-0","article-title":"Interpretable machine learning model for new-onset atrial fibrillation prediction in critically ill patients: a multi-center study","volume":"28","author":"Guan","year":"2024","journal-title":"Crit Care"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2019.09.009","article-title":"Machine learning for clinical decision support in infectious diseases: a narrative review of current applications","volume":"26","author":"Peiffer-Smadja","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"B29","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1186\/s12933-024-02278-z","article-title":"Comparison of triglyceride glucose index and modified triglyceride glucose indices in prediction of cardiovascular diseases in middle aged and older Chinese adults","volume":"23","author":"Cui","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/s12933-021-01391-7","article-title":"Gender difference in the association between TyG index and subclinical atherosclerosis: results from the I-Lan Longitudinal Aging Study","volume":"20","author":"Lu","year":"2021","journal-title":"Cardiovasc Diabetol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-023-01777-9","article-title":"U-shaped association between the triglyceride-glucose index and atrial fibrillation incidence in a general population without known cardiovascular disease","volume":"22","author":"Liu","year":"2023","journal-title":"Cardiovasc Diabetol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1186\/s12967-021-03164-y","article-title":"Sex-related differences of early cardiac functional and proteomic alterations in a rat model of myocardial ischemia","volume":"19","author":"Barta","year":"2021","journal-title":"J Transl Med"},{"key":"B33","doi-asserted-by":"publisher","first-page":"e1070\u2013e1079","DOI":"10.1210\/clinem\/dgaf573","article-title":"Insulin sensitivity and associated plasma proteomics during sex hormone therapy","volume":"111","author":"van Eeghen","year":"2025","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1864536\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T05:37:36Z","timestamp":1785217056000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1864536\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,28]]},"references-count":33,"alternative-id":["10.3389\/fendo.2026.1864536"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1864536","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,28]]},"article-number":"1864536"}}